1997
DOI: 10.1084/jem.185.11.1977
|View full text |Cite
|
Sign up to set email alerts
|

Selective Suppression of Interleukin-12 Induction after Macrophage Receptor Ligation

Abstract: Interleukin (IL)-12 is a monocyte- and macrophage-derived cytokine that plays a crucial role in both the innate and the acquired immune response. In this study, we examined the effects that ligating specific macrophage receptors had on the induction of IL-12 by lipopolysaccharide (LPS). We report that ligation of the macrophage Fcγ, complement, or scavenger receptors inhibited the induction of IL-12 by LPS. Both mRNA synthesis and protein secretion were diminished to near-undetectable levels following receptor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

22
288
3
2

Year Published

1998
1998
2008
2008

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 342 publications
(318 citation statements)
references
References 40 publications
22
288
3
2
Order By: Relevance
“…However, one would then expect that other cytokines, such as TNF␣, would also be down-regulated. A more plausible explanation may be that IC stimulation causes inhibition of IL-12 production by macrophages, as was previously reported by Sutterwala et al and Grazia Cappiello et al (58,59). Unfortunately, IL-12 production could not be detected in the culture supernatants, either in the presence or absence of HAGG stimulation (data not shown), leaving us unable to show this inhibition of IL-12 production in our in vitro system.…”
Section: Discussionsupporting
confidence: 53%
“…However, one would then expect that other cytokines, such as TNF␣, would also be down-regulated. A more plausible explanation may be that IC stimulation causes inhibition of IL-12 production by macrophages, as was previously reported by Sutterwala et al and Grazia Cappiello et al (58,59). Unfortunately, IL-12 production could not be detected in the culture supernatants, either in the presence or absence of HAGG stimulation (data not shown), leaving us unable to show this inhibition of IL-12 production in our in vitro system.…”
Section: Discussionsupporting
confidence: 53%
“…Besides phagocytosis, the opsonic iC3b potentially promotes immune suppression or tolerance in phagocytes through stimulating CR3-simultaneous CR3 ligation inhibits LPS induction of IL-12 from macrophages (35,36). IL-12 is produced by antigen-presenting cells (APCs), like macrophages and DCs, and plays a major role in host T differentiation into IFN-γ producing Th1 cells (37).…”
Section: The Role Of Opsonic Ic3b Beyond Ac Phagocytosismentioning
confidence: 99%
“…Ligation of the iC3b receptor CR3 on macrophages inhibits IL-12 production (35,36). Phagocytosis of iC3b-opsonized AC by DCs renders these cells tolerogenic (25).…”
Section: C1q In Immunity and Tolerancementioning
confidence: 99%
“…killing is indeed delayed (Melby, 1991). Inhibition of MP IL-12 production and resulting Th1 responses is not unique to Leishmania; viruses (Chehimi et al, 1994;Chougnet et al, 1996;Karp et 1996) and bacteria (Marth and Kelsall, 1997;Sutterwala et al, 1997;Matsunaga et al, 2003) also exploit this mechanism to avoid clearance.…”
Section: Introductionmentioning
confidence: 99%
“…killing is indeed delayed (Melby, 1991). Inhibition of MP IL-12 production and resulting Th1 responses is not unique to Leishmania; viruses (Chehimi et al, 1994;Chougnet et al, 1996;Karp et 1996) and bacteria (Marth and Kelsall, 1997;Sutterwala et al, 1997;Matsunaga et al, 2003) also exploit this mechanism to avoid clearance.The general nature of impaired IL-12 production in Leishmania spp.-infected MP has extended to every IL-12 agonist that has been tested. Leishmania spp.-infected MP are unable to produce IL-12 even in response to strong inflammatory stimuli, including microbial stimuli, e.g., lipopolysaccharide (LPS), Staphylococcus aureus (SAC), Toxoplasma gondii antigen, and mycobacteria (Carrera et al, 1996;Sartori et al, 1997;Belkaid et al, 1998;Weinheber et al, 1998;Piedrafita et al, 1999), and T-cell-dependent agonists, e.g., IFN-γ and CD40L (Carrera et al, 1996;Belkaid et al, 1998;Weinheber et al, 1998;Piedrafita et al, 1999).…”
mentioning
confidence: 99%